Critical Safety Gaps for Mental Health Applications Unknown effects on cognitive function, memory, personality, mood stability beyond intended therapeutic effect Long-term impacts on brain chemistry (chronic administration effects unexplored beyond 6 weeks in animals) Potential for psychological dependence or tolerance (not studied systematically) Impacts on developing brains in adolescents and young adults (completely unknown with no pediatric studies) Drug Interactions Pose Serious Concerns BPC-157s simultaneous effects on serotonin, dopamine, GABA, glutamate, and nitric oxide systems create multiple theoretical interaction points with psychiatric medications, yet interactions are not well studied. Specific concerns include: With SSRIs and SNRIs: Risk of serotonin syndrome is genuine
Although most people assume anemia is only an iron issue, there are a number of nutrients that play a role
Is BPC-157 and peptides in general safe for Pets
A clinical trial demonstrated that 6.8% of Wegovy-treated patients and 3.2% of placebo-treated patients discontinued due to adverse reactions, such as nausea, vomiting, and diarrhea
